Valganciclovir

HIV/AIDS

Valganciclovir

Registration certificate:

INN:

Valganciclovir

Release form:

Film-coated tablets

Therapeutic Area:

HIV/AIDS

Pharmacotherapeutic Group:

Antiviral agent

Conditions for dispensing:

On prescription

Packaging:

Indications for Use:

Treatment of cytomegalovirus (CMV) retinitis in adult patients with AIDS
Prevention of CMV infection following solid organ transplantation in adults and children over 16 years of age at risk

Valganciclovir is included in the List of Essential Medicines.